Gilles Gadea
10Patents
3h-index
19Co-inventors
49Inventor score
Filing activity: Sep 30, 2013 → Feb 3, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9108919B2 | Compounds useful for treating cancer | Chemistry; Metallurgy | 17 | Active |
| US9637475B2 | Compounds for treating cancer | Chemistry; Metallurgy | 12 | Active |
| US10253020B2 | Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging | Chemistry; Metallurgy | 8 | Active |
| US9969715B2 | Compounds useful for treating cancer | Chemistry; Metallurgy | 3 | Active |
| US10717724B2 | Compounds useful for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US11427566B2 | Compounds useful for treating cancer | Chemistry; Metallurgy | 0 | Active |
| US10590174B2 | Genomic sequences encoding for an attenuated mutant Zika virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US10849943B2 | Vaccine compositions comprising an attenuated mutant Zika virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US10920198B2 | Delta133p53beta and delta133p53gamma isoforms are biomarkers of cancer stem cells | Physics | 0 | Active |
| US12227767B2 | Delta133P53Beta and Delta133P53Gamma isoforms are biomarkers of cancer stem cells | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.